Office of The Director, National Institutes of Health; Notice of Meeting, 40066 [2021-15865]
Download as PDF
<![CDATA[
40066
Federal Register / Vol. 86, No. 140 / Monday, July 26, 2021 / Notices
improvements to such activities and
research.
The meeting will be held online
via webcast on August 26, 2021 from
approximately 9:00 a.m. to 5:00 p.m. ET
(times are tentative and subject to
change). The confirmed times and
agenda items for the meeting will be
posted on the TBDWG web page at
https://www.hhs.gov/ash/advisorycommittees/tickbornedisease/meetings/
2021-08-26/ when this
information becomes available.
DATES:
FOR FURTHER INFORMATION CONTACT:
jbell on DSKJLSW7X2PROD with NOTICES
James Berger, Designated Federal Officer
for the TBDWG; Office of Infectious
Disease and HIV/AIDS Policy, Office of
the Assistant Secretary for Health,
Department of Health and Human
Services, Mary E. Switzer Building, 330
C Street SW, Suite L600, Washington,
DC 20024. Email: tickbornedisease@
hhs.gov.
SUPPLEMENTARY INFORMATION:
Registration information can be found
on the meeting website at https://
www.hhs.gov/ash/advisory-committees/
tickbornedisease/meetings/2021-08-26/
index.html when it becomes available.
The public will have an opportunity to
present their views to the TBDWG orally
during the meeting’s public comment
session or by submitting a written
public comment. Comments should be
pertinent to the meeting discussion.
Persons who wish to provide verbal or
written public comment should review
instructions at https://www.hhs.gov/
ash/advisory-committees/
tickbornedisease/meetings/2021-08-26/
index.html and respond by midnight
August 17, 2021 ET. Verbal comments
will be limited to three minutes each to
accommodate as many speakers as
possible during the 30 minute session.
Written public comments will be
accessible to the public on the TBDWG
web page prior to the meeting.
Background and Authority: The TickBorne Disease Working Group was
established on August 10, 2017, in
accordance with Section 2062 of the
21st Century Cures Act, and the Federal
Advisory Committee Act, 5 U.S.C. App.,
as amended, to provide expertise and
review federal efforts related to all tickborne diseases, to help ensure
interagency coordination and minimize
overlap, and to examine research
priorities. The TBDWG is required to
submit a report to the HHS Secretary
and Congress on their findings and any
recommendations for the federal
response to tick-borne disease every two
years.
VerDate Sep<11>2014
17:10 Jul 23, 2021
Jkt 253001
Dated: July 9, 2021.
James J. Berger,
Designated Federal Officer, Tick-Borne
Disease Working Group, Office of Infectious
Disease and HIV/AIDS Policy.
[FR Doc. 2021–15830 Filed 7–23–21; 8:45 am]
BILLING CODE 4150–28–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Best Practices for Advancing Cultural
Competency, Language Access and
Sensitivity toward Asian Americans
and Pacific Islanders
Correction
In notice document 2021–15168,
appearing on pages 37757–37758 in the
issue of Friday, July 16, 2021, make the
following correction:
On page 37757, in the third column,
on the thirty-sixth line from the top,
‘‘minorityhealth@hhs.gov’’ should read
‘‘minorityhealth@hhs.gov.’’
[FR Doc. C1–2021–15168 Filed 7–23–21; 8:45 am]
BILLING CODE 0099–10–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of The Director, National
Institutes of Health; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Advisory Committee on
Research on Women’s Health.
The meeting will be held as a virtual
meeting and open to the public.
Individuals who plan to view the virtual
meeting and need special assistance or
other reasonable accommodations to
view the meeting, should notify the
Contact Person listed below in advance
of the meeting. The meeting will be
videocast and can be accessed from the
NIH Videocasting and Podcasting
website (https://videocast.nih.gov/).
Name of Committee: Advisory Committee
on Research on Women’s Health.
Date: September 1, 2021.
Time: 1:30 p.m. to 2:30 p.m.
Agenda: Presentation from the ACRWH
Working Group on the Women’s Health
Consensus Conference.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Samia Noursi, Ph.D.,
Associate Director, Science Policy, Planning,
and Analysis, Office of Research on Women’s
Health, National Institutes of Health, 6707
Democracy Blvd., Room 402, Bethesda, MD
20892, 301–496–9472, samia.noursi@nih.gov.
PO 00000
Frm 00077
Fmt 4703
Sfmt 9990
Name of Committee: Advisory Committee
on Research on Women’s Health.
Date: October 20, 2021.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: Reports on Congressionally
Recommended Women’s Health Priorities:
Rising Maternal Morbidity and Mortality
Rates; Rising Rates of Chronic Debilitating
Conditions in Women; and Stagnant Cervical
Cancer Survival Rates.
Date: October 21, 2021.
Time: 9:30 a.m. to 4:30 p.m.
Agenda: Director’s Report, NCI Director
Presentation, Women’s Health Consensus
Conference Working Group Report, and
concept clearances for various ORWH
programs.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Samia Noursi, Ph.D.,
Associate Director, Science Policy, Planning,
and Analysis, Office of Research on Women’s
Health, National Institutes of Health, 6707
Democracy Blvd., Room 402, Bethesda, MD
20892, 301–496–9472, samia.noursi@nih.gov.
Any member of the public interested in
presenting oral comments to the committee
may notify the Contact Person listed on this
notice at least 10 days in advance of the
meetings. Interested individuals and
representatives of organizations may submit
a letter of intent, a brief description of the
organization represented, and a short
description of the oral presentation. Only one
representative of an organization may be
allowed to present oral comments and if
accepted by the committee, presentations
may be limited to five minutes. Both printed
and electronic copies are requested for the
record. In addition, any interested person
may file written comments with the
committee by forwarding their statement to
the Contact Person listed on this notice. The
statement should include the name, address,
telephone number and when applicable, the
business or professional affiliation of the
interested person.
Information is also available on the
Institute’s/Center’s home page: https://
orwh.od.nih.gov/, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: July 21, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–15865 Filed 7–23–21; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\26JYN1.SGM
26JYN1
]]>Agencies
[Federal Register Volume 86, Number 140 (Monday, July 26, 2021)]
[Notices]
[Page 40066]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-15865]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of The Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Advisory Committee
on Research on Women's Health.
The meeting will be held as a virtual meeting and open to the
public. Individuals who plan to view the virtual meeting and need
special assistance or other reasonable accommodations to view the
meeting, should notify the Contact Person listed below in advance of
the meeting. The meeting will be videocast and can be accessed from the
NIH Videocasting and Podcasting website (https://videocast.nih.gov/).
Name of Committee: Advisory Committee on Research on Women's
Health.
Date: September 1, 2021.
Time: 1:30 p.m. to 2:30 p.m.
Agenda: Presentation from the ACRWH Working Group on the Women's
Health Consensus Conference.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Samia Noursi, Ph.D., Associate Director, Science
Policy, Planning, and Analysis, Office of Research on Women's
Health, National Institutes of Health, 6707 Democracy Blvd., Room
402, Bethesda, MD 20892, 301-496-9472, [email protected].
Name of Committee: Advisory Committee on Research on Women's
Health.
Date: October 20, 2021.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: Reports on Congressionally Recommended Women's Health
Priorities: Rising Maternal Morbidity and Mortality Rates; Rising
Rates of Chronic Debilitating Conditions in Women; and Stagnant
Cervical Cancer Survival Rates.
Date: October 21, 2021.
Time: 9:30 a.m. to 4:30 p.m.
Agenda: Director's Report, NCI Director Presentation, Women's
Health Consensus Conference Working Group Report, and concept
clearances for various ORWH programs.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Samia Noursi, Ph.D., Associate Director, Science
Policy, Planning, and Analysis, Office of Research on Women's
Health, National Institutes of Health, 6707 Democracy Blvd., Room
402, Bethesda, MD 20892, 301-496-9472, [email protected].
Any member of the public interested in presenting oral comments
to the committee may notify the Contact Person listed on this notice
at least 10 days in advance of the meetings. Interested individuals
and representatives of organizations may submit a letter of intent,
a brief description of the organization represented, and a short
description of the oral presentation. Only one representative of an
organization may be allowed to present oral comments and if accepted
by the committee, presentations may be limited to five minutes. Both
printed and electronic copies are requested for the record. In
addition, any interested person may file written comments with the
committee by forwarding their statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: https://orwh.od.nih.gov/, where an agenda and any additional
information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: July 21, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-15865 Filed 7-23-21; 8:45 am]
BILLING CODE 4140-01-P
